“健康中国2030”肝癌5年生存率提高15%的关键  

The key to 15%enhancement of 5-year survival for liver cancer for the plan of“HealthChina 2030”

作　　者：文天夫[1] 李川[1] 张晓赟[1] 彭伟[1] 沈俊颐 WEN Tianfu;LI Chuan;ZHANG Xiaoyun;PENG Wei;SHEN Junyi(Division of Liver Surgery,Department of General Surgery,West China Hospital,Sichuan University,Chengdu 610041,P.R.China)

机构地区：[1]四川大学华西医院普通外科,肝脏外科病房,成都610041

出　　处：《中国普外基础与临床杂志》2023年第11期1281-1283,共3页Chinese Journal of Bases and Clinics In General Surgery

基　　金：国家重点研发计划项目(项目编号:2022YFC2503701);四川省科技厅重点研发项目(项目编号:2022YFS0255)。

摘　　要：为迎接“健康中国2030”规划纲要要求、肿瘤总体5年生存率提高15%的巨大挑战,我们需要从以下3个方面去努力,实现肝癌5年生存率提高15%的目标:对70%的中晚期肝癌进行转化治疗与转化切除,延长生存;努力识别、治疗乙肝丙肝,筛查肝癌以降低肝癌发生和中晚期肝癌的比例;继续做好肝癌全程多学科规范化管理。To challenge the 15%enhancement of 5-year survival of cancer for the plan of“Health-China 2030”,we must strive the following measurements to complete the 15%enhancement of 5-year survival of liver cancer:conduct conversion therapy and conversion to resectability for the 70%of unresectable intermediate-to-advanced stage liver cancer so as to prolong survival;try our best to identify and treat the people of HBV and HCV infection,and to screen the risk people so as to reduce the incidence of liver cancer and the proportion for intermediate-to-advanced stage liver cancer;continue to try our best in the full course management of liver cancer under the frame of MDT.

关 键 词：肝癌 转化切除 筛查 乙型肝炎 多学科诊治 

分 类 号：R735.7[医药卫生—肿瘤]